<page><title>Myofibrillar myopathy</title><url>https://medlineplus.gov/genetics/condition/myofibrillar-myopathy</url><content>Myofibrillar myopathy
To use the sharing features on this page, please enable JavaScript.
Description
Myofibrillar myopathy is part of a group of disorders called
muscular dystrophies
that affect muscle function and cause weakness. Myofibrillar myopathy primarily affects skeletal muscles, which are muscles that the body uses for movement. In some cases, the heart (cardiac) muscle is also affected.
The signs and symptoms of myofibrillar myopathy vary widely among affected individuals, typically depending on the condition's genetic cause. Most people with this disorder begin to develop muscle weakness (myopathy) in mid-adulthood. However, features of this condition can appear anytime between infancy and late adulthood. Muscle weakness most often begins in the hands and feet (distal muscles), but some people first experience weakness in the muscles near the center of the body (proximal muscles). Other affected individuals develop muscle weakness throughout their body. Facial muscle weakness can cause swallowing and speech difficulties. Muscle weakness worsens over time.
Other signs and symptoms of myofibrillar myopathy can include a weakened heart muscle (cardiomyopathy), muscle pain (myalgia), loss of sensation and weakness in the limbs (peripheral neuropathy), and respiratory failure. Individuals with this condition may have skeletal problems including joint stiffness (contractures) and abnormal side-to-side curvature of the spine (
scoliosis
). Rarely, people with this condition develop clouding of the lens of the eyes (
cataracts
).
Frequency
The prevalence of myofibrillar myopathy is unknown.
Causes
Mutations in several genes can cause myofibrillar myopathy. These genes provide instructions for making proteins that play important roles in muscle fibers. Within muscle fibers, these proteins are involved in the assembly of structures called
sarcomeres
. Sarcomeres are necessary for muscles to tense (contract). The proteins associated with myofibrillar myopathy are normally active on rod-like structures within the sarcomere called Z-discs. Z-discs link neighboring sarcomeres together to form myofibrils, the basic unit of muscle fibers. The linking of sarcomeres and formation of myofibrils provide strength for muscle fibers during repeated muscle contraction and relaxation.
Gene mutations that cause myofibrillar myopathy disrupt the function of skeletal and cardiac muscle. Various muscle proteins form clumps (aggregates) in the muscle fibers of affected individuals. The aggregates prevent these proteins from functioning normally, which reduces linking between neighboring sarcomeres. As a result, muscle fiber strength is diminished.
At least six genes have been associated with myofibrillar myopathy. Mutations in these six genes account for approximately half of all cases of this condition. Mutations in the
DES
,
MYOT
, and
LDB3
genes are responsible for the majority of cases of myofibrillar myopathy when the genetic cause is known.
Learn more about the genes associated with Myofibrillar myopathy
DES
LDB3
MYOT
Additional Information from NCBI Gene:
BAG3
CRYAB
FLNC
Inheritance
This condition is inherited in an
autosomal dominant pattern
, which means one copy of the altered gene in each cell is sufficient to cause the disorder.
Other Names for This Condition
Myofibrillar myopathies
Additional Information &amp; Resources
Genetic Testing Information
Genetic Testing Registry: Desmin-related myofibrillar myopathy
Genetic Testing Registry: Myofibrillar myopathy 2
Genetic Testing Registry: Myofibrillar myopathy 4
Genetic Testing Registry: Myofibrillar myopathy 5
Genetic Testing Registry: Myofibrillar myopathy 6
Genetic Testing Registry: Myofibrillar myopathy
Genetic Testing Registry: Myofibrillar myopathy 3
Genetic and Rare Diseases Information Center
Myofibrillar myopathy
Patient Support and Advocacy Resources
National Organization for Rare Disorders (NORD)
Catalog of Genes and Diseases from OMIM
MYOPATHY, MYOFIBRILLAR, 1; MFM1
MYOPATHY, MYOFIBRILLAR, 2; MFM2
MYOPATHY, MYOFIBRILLAR, 3; MFM3
MYOPATHY, MYOFIBRILLAR, 4; MFM4
MYOPATHY, MYOFIBRILLAR, 5; MFM5
MYOPATHY, MYOFIBRILLAR, 6; MFM6
Scientific Articles on PubMed
PubMed
References
Ferrer I, Olive M. Molecular pathology of myofibrillar myopathies. Expert Rev
Mol Med. 2008 Sep 3;10:e25. doi: 10.1017/S1462399408000793.
Citation on PubMed
Schroder R, Schoser B. Myofibrillar myopathies: a clinical and myopathological
guide. Brain Pathol. 2009 Jul;19(3):483-92. doi:
10.1111/j.1750-3639.2009.00289.x.
Citation on PubMed
Selcen D, Ohno K, Engel AG. Myofibrillar myopathy: clinical, morphological and
genetic studies in 63 patients. Brain. 2004 Feb;127(Pt 2):439-51. doi:
10.1093/brain/awh052. Epub 2004 Jan 7.
Citation on PubMed
Selcen D. Myofibrillar myopathies. Curr Opin Neurol. 2010 Oct;23(5):477-81.
doi: 10.1097/WCO.0b013e32833d38b0.
Citation on PubMed
The information on this site should not be used as a substitute for professional medical care or advice. Contact a health care provider if you have questions about your health.
Official websites use .gov
A
.gov
website belongs to an official government
              organization in the United States.
Secure .gov websites use HTTPS
A
lock
(
Lock
Locked padlock icon
) or
https://
means youâ€™ve safely connected to
              the .gov website. Share sensitive information only on official,
              secure websites.</content></page>